Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Monitoring and Management of Hemolytic Disease of the Fetus and Newborn Based on an International Expert Delphi Consensus.
Mustafa HJ, Sambatur EV, Shamshirsaz AA, Johnson S, Moise KJ Jr, Baschat AA, Verweij EJTJ, Javinani A, Kilby MD, Lopriore E, Rose R, Devlieger R, Snowise S, Sachs UJ, Khalil A; HDFN Delphi Working Group. Mustafa HJ, et al. Among authors: verweij ejtj. Am J Obstet Gynecol. 2024 Nov 13:S0002-9378(24)01130-X. doi: 10.1016/j.ajog.2024.11.003. Online ahead of print. Am J Obstet Gynecol. 2024. PMID: 39547350
Design of a Phase 3, Global, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn.
Komatsu Y, Verweij EJTJ, Tiblad E, Lopriore E, Oepkes D, Agarwal P, Lam E, Leu JH, Ling LE, Nelson RM, Olusajo V, Saeed-Khawaja S, Tjoa ML, Zhou J, Amin U, Sirah W, Moise KJ. Komatsu Y, et al. Among authors: verweij ejtj. Am J Perinatol. 2024 Sep 17. doi: 10.1055/a-2404-8089. Online ahead of print. Am J Perinatol. 2024. PMID: 39197469 Free article.
Nipocalimab in Early-Onset Severe Hemolytic Disease of the Fetus and Newborn.
Moise KJ Jr, Ling LE, Oepkes D, Tiblad E, Verweij EJTJ, Lopriore E, Smoleniec J, Sachs UJ, Bein G, Kilby MD, Miller RS, Devlieger R, Audibert F, Emery SP, Markham K, Norton ME, Ocón-Hernández O, Pandya P, Pereira L, Silver RM, Windrim R, Streisand JB, Leu JH, Mirza A, Smith V, Schwartz LB, Tjoa ML, Saeed-Khawaja S, Komatsu Y, Bussel JB; UNITY Study Group. Moise KJ Jr, et al. Among authors: verweij ejtj. N Engl J Med. 2024 Aug 8;391(6):526-537. doi: 10.1056/NEJMoa2314466. N Engl J Med. 2024. PMID: 39115062 Clinical Trial.
Use and Waste of Reconstituted Whole Blood Exchange Transfusions: An 11-year National Observational Study.
de Winter DP, Lopriore E, Hulzebos CV, Lukens MV, Klinkspoor JHH, van Bohemen M, den Besten G, de Vooght KMK, Vrancken SLAG, Trompenaars AMP, Hoffmann-Haringsma A, Péquériaux NCVN, Andriessen P, Gijzen K, van Hillegersberg JLAMJ, Zant JC, van Rossem MC, van Gammeren AJA, Weerkamp F, Counsilman CE, Knol FRR, Schiering IAMI, Dubbink-Verheij GH, Verweij EJTJ, de Haas M; WISE investigators. de Winter DP, et al. Among authors: verweij ejtj. J Pediatr. 2024 Dec;275:114225. doi: 10.1016/j.jpeds.2024.114225. Epub 2024 Jul 31. J Pediatr. 2024. PMID: 39095011 Free article.
An exploratory open-label multicentre phase I/II trial evaluating the safety and efficacy of postnatal or prenatal and postnatal administration of allogeneic expanded fetal mesenchymal stem cells for the treatment of severe osteogenesis imperfecta in infants and fetuses: the BOOSTB4 trial protocol.
Sagar RL, Åström E, Chitty LS, Crowe B, David AL, DeVile C, Forsmark A, Franzen V, Hermeren G, Hill M, Johansson M, Lindemans C, Lindgren P, Nijhuis W, Oepkes D, Rehberg M, Sahlin NE, Sakkers R, Semler O, Sundin M, Walther-Jallow L, Verweij EJTJ, Westgren M, Götherström C. Sagar RL, et al. Among authors: verweij ejtj. BMJ Open. 2024 Jun 4;14(6):e079767. doi: 10.1136/bmjopen-2023-079767. BMJ Open. 2024. PMID: 38834319 Free PMC article.
15 results